NURTEC ODT is a Oral Tablet, Orally Disintegrating in the Human Prescription Drug category. It is labeled and distributed by Biohaven Pharmaceuticals, Inc. The primary component is Rimegepant Sulfate.
Product ID | 72618-3000_965a1ac5-b0c6-48a8-a63a-311c73baeac6 |
NDC | 72618-3000 |
Product Type | Human Prescription Drug |
Proprietary Name | NURTEC ODT |
Generic Name | Rimegepant Sulfate |
Dosage Form | Tablet, Orally Disintegrating |
Route of Administration | ORAL |
Marketing Start Date | 2020-03-05 |
Marketing Category | NDA / NDA |
Application Number | NDA212728 |
Labeler Name | Biohaven Pharmaceuticals, Inc |
Substance Name | RIMEGEPANT SULFATE |
Active Ingredient Strength | 75 mg/75mg |
Pharm Classes | Calcitonin Gene-related Peptide Receptor Antagonist [EPC],Calcitonin Gene-related Peptide Receptor Antagonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2020-03-05 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA212728 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2020-03-05 |
Ingredient | Strength |
---|---|
RIMEGEPANT SULFATE | 75 mg/75mg |
SPL SET ID: | 9ef08e09-1098-35cc-e053-2a95a90a3e1d |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
NURTEC ODT 88840180 not registered Live/Pending |
Biohaven Pharmaceutical Holding CompanyLtd. 2020-03-19 |